PrEP Use and Sexually Transmitted Infections Are Not Associated Longitudinally in a Cohort Study of Young Men Who Have Sex with Men and Transgender Women in Chicago
Our goal was to understand whether PrEP users are at increased risk for STIs, a key target in prevention efforts aimed at disrupting the spread of STIs and likely downstream HIV infection risk. Data were collected as part of RADAR, a cohort study of young men who have sex with men and transgender women (YMSM/TW) (aged 16–29) in Chicago. Longitudinal lagged regression models were utilized to assess the relationship between PrEP use and odds of rectal STI acquisition. Mediation models were also utilized to consider the potential pathway between PrEP use, condomless anal sex (CAS), and rectal STI. One hundred eighty-seven (16.2%) participants had a rectal STI at baseline. In both cross-sectional and longitudinal models, no significant association was observed between PrEP use and STI. In mediation models, PrEP use was significantly associated with increased CAS, however, CAS was not associated with STI status. We demonstrated that, overall, PrEP use was not associated with STIs among YMSM/TW but did observe that PrEP users were more likely to report increased participation in CAS at the subsequent study visit.
KeywordsHIV PrEP STI Longitudinal
This work was supported by grants from the National Institute on Drug Abuse at the National Institutes of Health (U01DA036939, PI: Mustanski; F32DA046313, PI: Morgan; R01MD013609, PI: Mustanski & Newcomb). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The sponsor had no involvement in the conduct of the research or the preparation of the article. The authors would like to thank the entire RADAR research team, particularly Dr. Thomas Remble and Antonia Clifford for overseeing the project and Daniel T. Ryan for data management. We also thank the RADAR participants for sharing their experiences with us.
- 1.Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2015. Atlanta: US Department of Health and Human Services; 2016.Google Scholar
- 2.Centers for Disease Control and Prevention. Gonorrhea. 10/18/2016 2016. https://www.cdc.gov/std/stats15/gonorrhea.htm. Accessed 26 July, 2016.
- 3.Centers for Disease Control and Prevention. Chlamydia. 10/18/2016 2016. https://www.cdc.gov/std/stats15/chlamydia.htm. Accessed 26 July, 2016.
- 4.Schillinger J. The intersection of PrEP and sexually transmitted infections. Conference on Retroviruses and Opportunisitic Infections (CROI); 2018; Boston, MA; 2018.Google Scholar
- 8.Montanto M, Dombrowksi JC, Barbee LA, Golden M, Khosropour C. Changes in sexual behavior and STI diagnoses among MSM using PrEP in Seattle, WA. Conference on Retroviruses and Opportunisitic Infections (CROI); 2017; Seattle, WA; 2017.Google Scholar
- 9.Centers for Disease Control and Prevention. Reported STDs in the United States 2014 national data for chlamydia, gonorrhea, and syphilis. Atlanta: CDC; 2015.Google Scholar
- 13.Nguyen VK, Greenwald ZR, Trottier H, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 2018;32(4):523–30.Google Scholar
- 14.Traeger M, Asselin J, Price B, et al. Changes, patterns and predictors of sexually transmitted infections in gay and bisexual men using PrEP—interim analysis from the PrEPX study. International AIDS Society (IAS); 2018; Amsterdam, Netherlands; 2018.Google Scholar
- 19.Mustanski B, Feinstein BA, Madkins K, Sullivan P, Swann G. Prevalence and risk factors for rectal and urethral sexually transmitted infections from self-collected samples among young men who have sex with men participating in the Keep It Up! 2.0 randomized controlled trial. Sex Transm Dis. 2017;44(8):483–8.CrossRefGoogle Scholar
- 22.Centers for Disease Control and Prevention. STDs and HIV: CDC Fact Sheet. 07/10/2017 2014. https://www.cdc.gov/std/hiv/stdfact-std-hiv.htm. Accessed 26 July, 2017.
- 24.Boyadzhyan B, Yashina T, Yatabe JH, Patnaik M, Hill CS. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2004;42(7):3089–93.CrossRefGoogle Scholar
- 28.Babor T, Higgins-Biddle J, Saunders J, Monteiro M. AUDIT, the Alcohol Use Disorders Identification test: guidelines for use in primary health care. Geneva: World Health Organization (WHO); 2001.Google Scholar